Institutional investors purchased a net $1.4 million shares of IMMU during the quarter ended March 2015, and now own 43.93% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIFESCI INDEX PARTNERS LLC Bought 4.6 Thousand shares of Immunomedics Inc